Concepedia

Stephen Jun Fei Chong

SJ

Statistics

Publications

10

Citations

347

H-Index

10

Active since

2015

Affiliations

National University of Singapore(Current)

Dana-Farber Cancer Institute

National University Cancer Institute, Singapore

National University Health System

Duke-NUS Medical School

Stephen Jun Fei Chong is an author at National University of Singapore specializing in oncology, bcl-2 family proteins, and molecular oncology.

ORCID

Publications per year

2015–2023

10

Publications

10

Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism

Stephen Jun Fei Chong, Kartini Iskandar, Jolin Xiao Hui Lai et al. · Nucleic Acids Research · 2020 · 63 citations · Full text

, , +17

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

Stephen Jun Fei Chong, Fen Zhu, Olga Dashevsky et al. · Journal of Clinical Investigation · 2023 · 43 citations · Full text

, , +16

Sustained IKKβ phosphorylation and NF-κB activation by superoxide-induced peroxynitrite-mediated nitrotyrosine modification of B56γ3 and PP2A inactivation

Yi Hui Yee, Stephen Jun Fei Chong, Li Ren Kong et al. · Redox Biology · 2020 · 42 citations · Full text

, , +17

Overexpression of Bcl-2 induces STAT-3 activation <i>via</i> an increase in mitochondrial superoxide

Jia Kang, Stephen Jun Fei Chong, Vignette Zi Qi Ooi et al. · Oncotarget · 2015 · 38 citations · Full text

, , +15

BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia

Charles Herbaux, Christoph Kornauth, Stéphanie Poulain et al. · Blood · 2021 · 37 citations · Full text

, , +11

1–5 of 10